PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.90%
Revenue growth at 50-75% of BIDU's 9.35%. Martin Whitman would worry about competitiveness or product relevance.
8.97%
Gross profit growth at 50-75% of BIDU's 13.08%. Martin Whitman would question if cost structure or brand is lagging.
25.40%
EBIT growth above 1.5x BIDU's 4.62%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
25.40%
Operating income growth above 1.5x BIDU's 4.62%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
22.04%
Positive net income growth while BIDU is negative. John Neff might see a big relative performance advantage.
22.88%
Positive EPS growth while BIDU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.08%
Positive diluted EPS growth while BIDU is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.88%
Share reduction while BIDU is at 0.21%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.46%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
21.94%
OCF growth under 50% of BIDU's 82.05%. Michael Burry might suspect questionable revenue recognition or rising costs.
26.47%
FCF growth under 50% of BIDU's 74.39%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
455.27%
10Y revenue/share CAGR 1.25-1.5x BIDU's 349.47%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
150.51%
5Y revenue/share CAGR above 1.5x BIDU's 30.77%. David Dodd would look for consistent product or market expansions fueling outperformance.
109.68%
3Y revenue/share CAGR above 1.5x BIDU's 28.29%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
539.62%
10Y OCF/share CAGR above 1.5x BIDU's 231.02%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
210.25%
OCF/share CAGR of 210.25% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
120.50%
3Y OCF/share CAGR above 1.5x BIDU's 27.33%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
497.37%
Net income/share CAGR above 1.5x BIDU's 96.64% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
530.41%
Positive 5Y CAGR while BIDU is negative. John Neff might view this as a strong mid-term relative advantage.
184.10%
3Y net income/share CAGR above 1.5x BIDU's 42.77%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
255.67%
Below 50% of BIDU's 652.59%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
80.83%
5Y equity/share CAGR 1.25-1.5x BIDU's 57.63%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
38.69%
3Y equity/share CAGR similar to BIDU's 40.48%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.68%
AR growth well above BIDU's 2.63%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.63%
Inventory is declining while BIDU stands at 0.65%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.67%
Asset growth above 1.5x BIDU's 1.33%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.31%
BV/share growth above 1.5x BIDU's 2.16%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.17%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-7.67%
Our R&D shrinks while BIDU invests at 17.67%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-0.29%
We cut SG&A while BIDU invests at 16.16%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.